1. Fowler VG Jr, Scheid WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Elsevier, 2005:975-1022.

2. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98: 2936-2948.

3. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-1320.

4. Habib B. Management of infective endocarditis. Heart 2006;92: 124-130.

5. Baddour LM, Wilson WR, Bayer AS, et al. American Heart Association Scientific Statement. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications. Circulation 2005;111: e394-e433.

6. Millar BC, Moore JE. Emerging issues in infective endocarditis. Emerg Infect Dis 2004;10:110-116.

7. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation 2007;116:1736-1754.

8. Moreillon P, Que Y. Infective endocarditis. Lancet 2004;363:139-149.

9. Baddour LM, Wilson WR. Infections of prosthetic valves and other cardiovascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Elsevier, 2005:1022-1044.

10. Karchmer AW. Infective endocarditis. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 6th ed. Philadelphia: Saunders, 2001:1723-1748.

11. Cecchi E, Imazio M, Trinchero R. Infective endocarditis: Diagnostic issues and practical clinical approach based on echocardiography. J Cardiovasc Med 2008;9:414-418.

12. Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective endocarditis. Cardiol Clin 2003;21:185-195.

13. Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001;37:1069-1076.

Durack DT, Lukes AS, Bright DK Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiography findings. Am J Med 1994;96:200-209.

Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.

Bridger A. Infective endocarditis: New strategies for diagnosis and prophylaxis. JAAPA 2001;14:35-47.

Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94.

Fowler VG Jr., Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA 2005;293:3012-3021.

Hoen B. Special issues in the management of infective endocarditis caused by gram-positive cocci. Infect Dis Clin North Am 2002;16:437-452.

Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Circulation 2002;105:2115-2127.

Knoll B, Tleyjeh IM, Steckelberg JM, et al. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis 2007;44:1585-1592.

Upton A, Drinkovic D, Pottumarthy S, et al. Culture results of heart valves resected because of streptococcal endocarditis: Insights into duration of treatment to achieve valve sterilization. J Antimicrob Chemother 2005;55:234-239.

Murray RJ. Staphylococcus aureus infective endocarditis: Diagnosis and management guidelines. Intern Med J 2005;35:S25-S44.

Petti CA, Fowler VG Jr. Staphylococcus aureus bacteremia and endocarditis. Cardiol Clin 2003;21:219-233.

Miele PS, Kogulan PK, Levy CS, et al. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. Am Heart J 2001;142:571-576.

Woods CW, Cheng AC, Fowler VG Jr, et al. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 2004;38:1188-1191.

Centers for Disease Control. Staphylococcus aureus resistant to vancomy-cin—United States, 2002. MMWR 2002;51:565-567.

Millar BC, Prendergast BD, Moore JE. Community-associated MRSA (CA-MRSA): An emerging pathogen in infective endocarditis. J Antimicrob Chemother 2008;61:1-7.

Anguera I, Del Rio A, Miro JM, et al. Staphylococcus lugdunensis infective endocarditis: Description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 2005;91:e10.

Van Hoovels L, De Munter P, Colaert J, et al. Three cases of destructive native valve endocarditis caused by Staphylococcus lugdunensis. Eur J Clin Microbiol Infect Dis 2005;24:149-152.

Frank KL, Luiz del Pozo J, Patel R. From clinical microbiology to infection pathogenesis: How daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 2008;21:111-133.

Burgert SJ. Destructive native valve endocarditis caused by Staphylococcus lugdunensis. South Med J 1999;92:812-814.

Linden PK. Optimizing therapy for vancomycin-resistant enterococci (VRE). Semin Respir Crit Care Med 2007;28:632-645.

Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-207.

Feder HM Jr., Roberts JC, Salazar JC, et al. HACEK endocarditis in infants and children: Two cases and a literature review. Pediatr Infect Dis J 2003;22:557-562.

Naber CK, Erbel R. Diagnosis of culture negative endocarditis: Novel strategies to prove the suspect guilty. Heart 2003;89:241-243.

Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med 2007;147:829-835.

Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: Etiologic diagnosis of 348 cases. Medicine 2005;84:162-173.

Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis: Evidence in the world literature, 1965-1995. Clin Infect Dis 2001;32:50-62.

Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002;122:302-310.

Fowler V, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and infective endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-665.

42. Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients. Pharmacotherapy 2006;26:347-352.

43. Nathani N, Iles P, Elliott TSJ. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: A case report. J Infect 2005;51:e213-e215.

44. Corne P, Marchandin H, Macia J-C, Jonquet O. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid. Scand J Infect Dis 2005;37:946-949.

45. Drew RH, Perfect JR, Srinath L, et al. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin/dalfopristin in patients intolerant of/or failing prior therapy: For the Synercid Emergency-Use Study Group. J Antimicrob Chemother 2000;46:775-784.

46. Rajendram R, Alp NJ, Mitchell AR, et al. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005;40:e72-e74.

47. Reis LJ, Barton TD, Pochettino A, et al. Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole. Clin Infect Dis 2005;41:752-753.

48. Sohail MR, Martin KR, Wilson WR, et al. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med 2006;119:147-154.

49. Rivas P, Alonso J, Moya J, et al. The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis. Chest 2005;128:764-771.

50. Akowuah EF, Davies W, Oliver S. Prosthetic valve endocarditis: Early and late outcome following medical or surgical treatment. Heart 2003;89:269-272.

75 Tuberculosis

Charles A. Peloquin and Rocsanna Namdar


Lower Your Cholesterol In Just 33 Days

Lower Your Cholesterol In Just 33 Days

Discover secrets, myths, truths, lies and strategies for dealing effectively with cholesterol, now and forever! Uncover techniques, remedies and alternative for lowering your cholesterol quickly and significantly in just ONE MONTH! Find insights into the screenings, meanings and numbers involved in lowering cholesterol and the implications, consideration it has for your lifestyle and future!

Get My Free Ebook

Post a comment